Intrinsic Value and How to Think About It
Intrinsic value is the cornerstone of every serious investment decision. It represents what a business is actually worth based on its ability to generate cash for its owners over time, independent of whatever price the stock market assigns on any given day. Every share of stock is a claim on a real business with real assets, real earnings, and real growth prospects. Intrinsic value is the attempt to quantify that claim. Without an estimate of intrinsic value, an investor has no basis for determining whether a stock is cheap, fairly priced, or expensive. They are simply guessing.
The concept is straightforward in theory but demands significant judgment in practice. Two analysts looking at the same company can arrive at different intrinsic value estimates based on their assumptions about future growth, profitability, capital requirements, and the appropriate discount rate. This uncertainty is not a flaw in the framework. It is an honest reflection of the fact that the future is unknowable. The goal is not to produce a precise number but to develop a well-reasoned range and then act only when the market price sits far enough below that range to provide a margin of safety.
The Definition
Benjamin Graham defined intrinsic value as "that value which is justified by the facts, e.g., assets, earnings, dividends, definite prospects." Warren Buffett simplified it further: "Intrinsic value is the discounted value of the cash that can be taken out of a business during its remaining life." Both definitions point to the same underlying reality. A business is worth the cash it will produce.
This is distinct from book value, which is an accounting concept based on historical cost. It is distinct from market value, which is whatever price buyers and sellers agree upon at any moment. And it is distinct from liquidation value, which is what the assets would fetch if the company were shut down and sold off. Intrinsic value is forward-looking. It depends on what the business will do in the future, not what it has done in the past or what its balance sheet says today.
A simple example illustrates the concept. Imagine a toll bridge that generates $1 million in free cash flow per year, requires minimal maintenance capital, and will operate indefinitely. If an appropriate discount rate is 10%, the intrinsic value of that bridge is approximately $10 million ($1 million divided by 10%). If someone offers to sell the bridge for $6 million, a significant margin of safety exists. If they want $15 million, the asset is overpriced regardless of how many cars cross it each day.
Discounted Cash Flow Analysis
The most theoretically rigorous approach to estimating intrinsic value is discounted cash flow (DCF) analysis. A DCF model projects a company's future free cash flows, typically over a 5-to-10-year explicit forecast period, then estimates a terminal value for all cash flows beyond that period, and discounts everything back to the present at the weighted average cost of capital (WACC).
The formula for intrinsic value under a DCF framework is:
Intrinsic Value = Sum of [FCF(t) / (1 + r)^t] + Terminal Value / (1 + r)^n
Where FCF(t) is free cash flow in year t, r is the discount rate, and n is the length of the explicit forecast period.
Consider Microsoft in early 2023. The company generated approximately $63 billion in free cash flow in fiscal year 2022. An analyst projecting 10% annual FCF growth for 10 years, a terminal growth rate of 3%, and a WACC of 9% would estimate an intrinsic value roughly in the range of $250-280 per share, depending on exact assumptions about capital expenditures, working capital changes, and share count. The stock was trading around $240-250 at that time, suggesting it was approximately fairly valued under those assumptions.
The power of DCF analysis is its explicitness. Every assumption is stated and can be debated. The weakness is its sensitivity to those assumptions. Small changes in growth rates, discount rates, or terminal values can produce large swings in the output. A 1% change in WACC on a company like Microsoft can shift the intrinsic value estimate by 15-20%. A 1% change in the terminal growth rate can shift it by 10-15%.
This sensitivity is why experienced practitioners treat DCF outputs as rough guides rather than definitive answers. The model is most useful for understanding what assumptions are embedded in the current stock price (reverse DCF) and for stress-testing scenarios. If a stock requires heroic growth assumptions to justify its price, it is probably overvalued. If it is cheap even under conservative assumptions, it may be a genuine bargain.
Earnings Power Value
Earnings power value (EPV), developed by Columbia Business School professor Bruce Greenwald, takes a different approach. Instead of projecting future growth, EPV asks a simpler question: what is the business worth based on its current, sustainable earnings alone, with zero growth?
The formula is:
EPV = Adjusted Earnings / Cost of Capital
Adjusted earnings start with reported earnings but strip out one-time items, excessive depreciation or amortization, and cyclical distortions to arrive at a figure that represents what the business can earn in a normal year. This figure is then divided by the cost of capital (typically the cost of equity for an all-equity-financed firm) to produce a perpetuity value.
The logic behind EPV is that growth only creates value when a company earns returns above its cost of capital. If a company reinvests at exactly its cost of capital, growth adds nothing to intrinsic value. If it reinvests below its cost of capital, growth actually destroys value. By excluding growth entirely, EPV provides a conservative floor estimate of intrinsic value. Any value attributed to growth is then viewed as a bonus that requires additional evidence to justify.
EPV is particularly useful for mature, stable businesses. A company like Coca-Cola, with predictable earnings, modest growth, and a dominant market position, is well-suited to EPV analysis. If the stock price is below EPV, there is no need to make growth assumptions at all. The business is undervalued purely on its current earnings power.
Asset-Based Valuation
Asset-based valuation estimates intrinsic value by examining what the company's assets are worth, either in continued use or in liquidation. Graham was a proponent of this approach, particularly his "net-net" strategy, which involved buying stocks trading below their net current asset value (current assets minus total liabilities).
Net current asset value = Current Assets - Total Liabilities
A company trading below this threshold is essentially being valued at less than the cash, receivables, and inventory on its balance sheet, after paying off all debts. This is an extraordinarily conservative measure. It ignores the value of fixed assets, brand value, customer relationships, and the ongoing earning power of the business entirely.
Graham found that portfolios of net-net stocks, bought mechanically and held for one to two years, produced average returns of approximately 20% annually. The approach worked because these deeply distressed valuations often reflected excessive pessimism rather than genuine insolvency risk. Many of the companies recovered, were acquired, or liquidated at prices above the purchase price.
Asset-based valuation remains relevant today, though net-net opportunities are far rarer than in Graham's era. The approach is most applicable to financial institutions (where book value is a reasonable proxy for economic value), natural resource companies (where the value of reserves can be estimated independently), and real estate holding companies (where the properties have appraised values).
Relative Valuation
Relative valuation, or comparable company analysis, estimates intrinsic value by comparing a company's valuation metrics to those of similar businesses. If Pepsi trades at 24 times earnings and Coca-Cola trades at 20 times earnings, an analyst might argue that Coca-Cola is undervalued relative to its closest peer, assuming the two companies have similar growth prospects, profitability, and risk profiles.
Common multiples used in relative valuation include price-to-earnings (P/E), enterprise value-to-EBITDA (EV/EBITDA), price-to-free-cash-flow (P/FCF), and price-to-book (P/B). Each has strengths and limitations depending on the industry and the specific company.
Relative valuation is quick, intuitive, and widely used on Wall Street. It is also potentially circular. If an entire sector is overvalued, a stock that looks cheap relative to its peers may still be expensive in absolute terms. During the dot-com bubble, a stock trading at 50 times earnings might have looked like a bargain compared to competitors at 200 times earnings. It was still vastly overpriced.
The best use of relative valuation is as a supplement to absolute methods like DCF or EPV. If a stock appears undervalued on both an absolute and relative basis, the case is stronger than if it is cheap by only one measure.
Why Precision Is Impossible (and Unnecessary)
Buffett has said that he would rather be approximately right than precisely wrong. This captures the right attitude toward intrinsic value estimation. Any honest attempt to value a business involves dozens of assumptions about future revenues, margins, capital expenditures, competitive dynamics, management quality, and macroeconomic conditions. Each assumption introduces uncertainty. The compounding of these uncertainties means that any single-point estimate of intrinsic value is almost certainly wrong.
The appropriate response is not to abandon the effort but to work in ranges. Instead of concluding that a stock is worth exactly $74.50, a thoughtful analyst might conclude that intrinsic value falls somewhere between $60 and $90 under a reasonable range of assumptions. If the stock is trading at $45, there is likely a margin of safety across the entire range. If it is trading at $75, the picture is ambiguous. If it is trading at $110, it is probably overvalued regardless of which assumptions prove correct.
This range-based thinking also clarifies which companies are easier to value than others. A regulated utility with stable cash flows and a long operating history has a relatively narrow range of reasonable intrinsic value estimates. A pre-revenue biotech company with a single drug in Phase 2 trials has an enormous range. Value investors tend to gravitate toward the former category, not because the returns are necessarily higher, but because the analysis is more reliable and the risk of permanent capital loss is lower.
Common Mistakes in Intrinsic Value Estimation
Several errors appear repeatedly in amateur and even professional valuation work.
Anchoring to the current stock price. The most insidious mistake is allowing the current market price to influence the intrinsic value estimate. If a stock is trading at $80, there is a strong psychological pull to arrive at an intrinsic value estimate somewhere near $80. The way to combat this is to build the valuation model before looking at the stock price, or at minimum, to be aware of the anchoring tendency and actively resist it.
Projecting recent growth indefinitely. A company that grew earnings at 25% for the past five years will not grow at 25% forever. Growth rates mean-revert as companies scale. The larger a company becomes, the harder it is to maintain high percentage growth. Projecting recent high growth rates more than a few years into the future almost always leads to overvaluation.
Using the wrong discount rate. The discount rate should reflect the riskiness of the cash flows being discounted. Using a low discount rate for a cyclical, leveraged business inflates the intrinsic value estimate. Using a high discount rate for a stable, monopoly-like business understates it. Many analysts use a single "standard" discount rate for all companies, which is a shortcut that distorts results.
Ignoring capital requirements. Revenue growth means nothing if the company must reinvest every dollar of earnings to generate that growth. Free cash flow, not earnings, is what matters to shareholders. A company growing earnings at 15% while requiring massive capital expenditures may generate less free cash flow than a company growing at 5% with minimal reinvestment needs.
Neglecting the balance sheet. A company with $10 billion in cash and no debt is worth more than an identical company with no cash and $10 billion in debt, even if their income statements look the same. Enterprise value, not market capitalization, is the right starting point for valuation. Excess cash adds to intrinsic value. Debt subtracts from it.
Putting It Into Practice
The practical approach to intrinsic value estimation involves multiple steps. First, understand the business. What does it sell, who buys it, what are the competitive dynamics, and what drives profitability? Second, analyze the financials. Study at least five years of income statements, balance sheets, and cash flow statements to understand the company's earning power, capital intensity, and financial health. Third, build a valuation using at least two different methods. Compare the results. If they converge, the estimate is more reliable. If they diverge widely, more work is needed to understand why.
Fourth, and this is where most investors fall short, stress-test the assumptions. What happens to the valuation if growth slows by 3%? What if margins contract by 200 basis points? What if the cost of capital rises by 1%? A valuation that only works under the most optimistic assumptions is not a valuation. It is a hope.
The discipline of intrinsic value estimation does not guarantee investment success. But it transforms investing from a game of sentiment and momentum into an exercise in business analysis and probability assessment. That transformation, from speculator to analyst, is the foundation on which every lasting investment career is built.
Put these principles into practice. Track fundamentals, build portfolios, and analyze stocks with AI-powered insights.
Start Free on GridOasis →